Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent Deferred Tax AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GE HealthCare Technologies (GEHC) Current Deferred Revenue (2022 - 2025)

Historic Current Deferred Revenue for GE HealthCare Technologies (GEHC) over the last 4 years, with Q4 2025 value amounting to $2.9 billion.

  • GE HealthCare Technologies' Current Deferred Revenue rose 1027.01% to $2.9 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.9 billion, marking a year-over-year increase of 1027.01%. This contributed to the annual value of $2.9 billion for FY2025, which is 1027.01% up from last year.
  • According to the latest figures from Q4 2025, GE HealthCare Technologies' Current Deferred Revenue is $2.9 billion, which was up 1027.01% from $2.8 billion recorded in Q3 2025.
  • GE HealthCare Technologies' 5-year Current Deferred Revenue high stood at $2.9 billion for Q4 2025, and its period low was $2.5 billion during Q4 2022.
  • Its 4-year average for Current Deferred Revenue is $2.7 billion, with a median of $2.6 billion in 2023.
  • In the last 5 years, GE HealthCare Technologies' Current Deferred Revenue plummeted by 428.94% in 2024 and then soared by 1027.01% in 2025.
  • GE HealthCare Technologies' Current Deferred Revenue (Quarter) stood at $2.5 billion in 2022, then rose by 3.84% to $2.6 billion in 2023, then rose by 0.23% to $2.6 billion in 2024, then rose by 10.27% to $2.9 billion in 2025.
  • Its Current Deferred Revenue was $2.9 billion in Q4 2025, compared to $2.8 billion in Q3 2025 and $2.7 billion in Q2 2025.